Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pelubiprofen vs Celebrex in Rheumatoid Arthritis
NCT01781702Phase 3Completed
- Sponsor
- Daewon Pharm
- Start
- Oct 2010
- Primary completion
- Oct 2011
01
Overview
Phase 3, randomised, double-blind trial of pelubiprofen in rheumatoid arthritis (RA), sponsored by Daewon Pharm. Primary endpoint: 100 mm Pain Visual Analog Scale at 42 days. Started Oct 2010; status: completed.
02
Drugs
pelubiprofen
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01781702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01781702.